Stocks · Health care · Surgical & Medical Instruments & Apparatus

Bioventus Inc.

BVS Clue Score54
United States Fiscal year ends December CIK 0001665988 Results filed 2 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John A. Bartholdson
19 Aug 2024
Director
Buy indirect
25,500
$8.55
$217.97K
John A. Bartholdson
16 Aug 2024
Director
Buy indirect
80,000
$8.55
$683.74K
Anthony P Bihl III
18 Aug 2023
Interim CEO
Buy indirect
26,595
$4.14
$110.07K
Anthony P Bihl III
18 Aug 2023
Interim CEO
Buy
13,290
$4.14
$55.00K
Juniper Investment Company, LLC
14 Aug 2023
10% owner
Buy indirect
14,985
$4.79
$71.78K
John A. Bartholdson
14 Aug 2023
Director
Buy indirect
14,985
$4.79
$71.75K
Juniper Investment Company, LLC
11 Aug 2023
10% owner
Buy indirect
50,037
$4.56
$228.17K
John A. Bartholdson
11 Aug 2023
Director
Buy indirect
50,037
$4.60
$229.94K
John A. Bartholdson
10 Aug 2023
Director
Buy indirect
111,848
$4.47
$500.42K
Juniper Investment Company, LLC
10 Aug 2023
10% owner
Buy indirect
111,848
$4.47
$499.96K
John A. Bartholdson
15 Jun 2023
Director
Buy indirect
110,180
$3.61
$397.66K
John A. Bartholdson
14 Jun 2023
Director
Buy indirect
181,946
$3.24
$589.52K
John A. Bartholdson
13 Jun 2023
Director
Buy indirect
60,324
$3.05
$183.91K
John A. Bartholdson
12 Jun 2023
Director
Buy indirect
395,401
$2.92
$1.15M
William A Hawkins
25 May 2023
Director
Buy
44,000
$2.66
$117.18K
William A Hawkins
24 May 2023
Director
Buy
44,000
$2.69
$118.39K
Anthony P Bihl III
23 May 2023
Interim CEO
Buy
125,000
$2.33
$290.99K
John A. Bartholdson
22 May 2023
Director
Buy indirect
178,998
$2.08
$372.30K
John A. Bartholdson
19 May 2023
Director
Buy indirect
1,136,675
$1.94
$2.20M
Kenneth Michael Reali
9 Sep 2021
Chief Executive Officer
Buy
1,800
$14.81
$26.66K
Katrina J Church
11 Feb 2021
SVP & Chief Compliance Officer
Buy
2,500
$13.00
$32.50K
John Nosenzo
11 Feb 2021
Chief Commercial Officer
Buy
500
$13.00
$6.50K
Kenneth Michael Reali
11 Feb 2021
Chief Executive Officer
Buy
9,375
$13.00
$121.88K
Gregory O. Anglum
11 Feb 2021
SVP & General Counsel
Buy
6,000
$13.00
$78.00K
Anthony D'Adamio
11 Feb 2021
SVP & General Counsel
Buy
1,000
$13.00
$13.00K
Alessandra Pavesio
11 Feb 2021
SVP & Chief Science Officer
Buy
1,000
$13.00
$13.00K

What was left out

Form 4 filings counted 218
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 5,582,044
Sales filed before the plan box existed 10
History held since 16 Feb 2021